Cargando…
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
RATIONALE: The activity of the transcription factor, hypoxia-inducible factor (HIF)-1α, is a common driver of a number of the pathways involved in the aggressiveness of glioblastomas (GBMs), and it has been suggested that the reduction in this activity observed, soon after the administration of temo...
Autores principales: | Lo Dico, Alessia, Martelli, Cristina, Diceglie, Cecilia, Lucignani, Giovanni, Ottobrini, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036118/ https://www.ncbi.nlm.nih.gov/pubmed/30013951 http://dx.doi.org/10.3389/fonc.2018.00249 |
Ejemplares similares
-
Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma
por: Lo Dico, Alessia, et al.
Publicado: (2019) -
Optical imaging probes in oncology
por: Martelli, Cristina, et al.
Publicado: (2016) -
The Multifaceted Role of CMA in Glioma: Enemy or Ally?
por: Lo Dico, Alessia, et al.
Publicado: (2021) -
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017) -
Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
por: Lo Dico, Alessia, et al.
Publicado: (2019)